Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) started the day on January 12, 2021, with a price decrease of -5.50% at $29.54. During the day, the stock rose to $31.70 and sunk to $28.62 before settling in for the price of $31.26 at the close. Taking a more long-term approach, ICPT posted a 52-week range of $23.78-$114.99.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 170.50%. Meanwhile, its Annual Earning per share during the time was 4.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -0.20%. This publicly-traded company’s shares outstanding now amounts to $32.99 million, simultaneously with a float of $27.80 million. The organization now has a market capitalization sitting at $976.89 million. At the time of writing, stock’s 50-day Moving Average stood at $32.25, while the 200-day Moving Average is $51.34.
If we measure the efficiency of the company that is accounted for 583 employees. It has generated 432,250 per worker during the last fiscal year. Meanwhile, its income per employee was -591,220. The stock had 7.91 Receivables turnover and 0.40 Total Asset turnover. For the Profitability, stocks gross margin was +94.74, operating margin was -123.98 and Pretax Margin of -136.78.
Intercept Pharmaceuticals Inc. (ICPT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Intercept Pharmaceuticals Inc.’s current insider ownership accounts for 14.20%, in contrast to 89.10% institutional ownership. According to the most recent insider trade that took place on Jan 05, this organization’s CFO and Treasurer sold 2,193 shares at the rate of 24.47, making the entire transaction reach 53,663 in total value, affecting insider ownership by 23,764. Preceding that transaction, on Dec 15, Company’s CFO and Treasurer sold 1,763 for 32.78, making the whole transaction’s value amount to 57,791. This particular insider is now the holder of 27,158 in total.
Intercept Pharmaceuticals Inc. (ICPT) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$2.01 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$1.93) by -$0.08. This company achieved a net margin of -136.78 while generating a return on equity of -975.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.56 per share during the current fiscal year.
Intercept Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -0.20% and is forecasted to reach -6.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -8.89% through the next 5 years, which can be compared against the 4.40% growth it accomplished over the previous five years trading on the market.
Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) Trading Performance Indicators
Let’s observe the current performance indicators for Intercept Pharmaceuticals Inc. (ICPT). It’s Quick Ratio in the last reported quarter now stands at 3.40. The Stock has managed to achieve an average true range (ATR) of 2.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.25.
In the same vein, ICPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.78, a figure that is expected to reach -1.49 in the next quarter, and analysts are predicting that it will be -6.45 at the market close of one year from today.
Technical Analysis of Intercept Pharmaceuticals Inc. (ICPT)
If we take a close look at the recent performances of Intercept Pharmaceuticals Inc. (NASDAQ: ICPT), its last 5-days Average volume was 1.22 million that shows plunge from its year to date volume of 1.43 million. During the previous 9 days, stock’s Stochastic %D was recorded 86.05% While, its Average True Range was 2.13.
Raw Stochastic average of Intercept Pharmaceuticals Inc. (ICPT) in the period of the previous 100 days is set at 21.35%, which indicates a major fall in contrast to 72.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 85.61% that was higher than 70.89% volatility it exhibited in the past 100-days period.